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ABSTRACT
Cutaneous chronic graft versus host disease has traditionally been classified into lichenoid and scleroderma-
like forms. However, the initial presentation is sometimes subtle and a variety of less common cutaneous
manifestation may be prevalent. This clinical review focuses on the lesional morphology of chronic graft versus
host disease, and presents a classification system that may prove useful in early diagnosis. In addition, this
approach may help to facilitate the correlation of different morphologic entities with outcome and response to
therapy.
© 2006 American Society for Blood and Marrow Transplantation
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Hematopoietic stem cell transplantation (HSCT)
sing peripheral blood, cord blood, or bone marrow is
sed to treat a wide variety of genetic and immunologic
isorders and hematologic and solid organ malignancies.
igniﬁcant advances in technology and immunology
ave improved the prognosis, rate of engraftment and
uality of life for many stem cell recipients. Chronic
raft-versus-host disease (cGVHD) is a multisystem dis-
ase often presenting with prominent skin involvement.
Traditionally, two types of cutaneous GVHD
ave been described: the acute form that occurs 100
ays after transplantation and the chronic form that
ccurs 100 days. These rigid time-related criteria
hould serve only as a guide, especially as HSCT
ractices change. Since the availability of new, less
ntensive preparative regimens and the use of donor
ymphocyte infusions, it is not uncommon to see a
elayed or late acute GVHD (aGVHD; ie, 100 days
fter transplantation) and, in some cases, overlapping
GVHD and cGVHD, or other “atypical” forms of
GVHD. Acute GVHD and cGVHD in the skin are
ore accurately diagnosed by clinical and, less fre-
uently, histopathologic features [1]. Based on simi-
arities with other dermatologic diseases, we de- acribe and summarize the diversity of cutaneous
anifestations of cGVHD in Table 1. In our pa-
ients, the diagnosis of cutaneous GVHD was con-
rmed by a combination of elements including the
linical course and the presence of GVHD in other
rgan systems. All of our patients also had patho-
ogic conﬁrmation. By speciﬁcally describing le-
ional morphology, we hope to achieve a common,
ystematic, and consistent terminology for cutane-
us cGVHD. This approach may also facilitate the
orrelation of different morphologic entities with out-
ome and response to therapy.
LINICAL DESCRIPTION
Early on, the skin lesions of cGHVD are often
ubtle and the progression is insidious, characterized
y the development of marked xerosis (skin dryness),
ollicular prominence (Figure 1), and ichthyosis (ﬁsh
cale-like skin) (Figure 2). Papulosquamous lesions
ay simulate the appearance of keratosis pilaris (Fig-
re 3) or present with pityriasiform (annular plaques
emonstrating a branny scale), eczematous, or psori-
siform plaques (Figure 4).
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S. R. Hymes et al.1102The lichen planus-like lesions of cGVHD are in-
istinguishable clinically and histologically from clas-
ic lichen planus. The lesions can be focal (Figure 5a),
onﬂuent (Figure 5b), linear (Figure 5c) [2], folliculo-
able 1. Cutaneous Chronic Graft-versus-Host Disease
Clinical Pattern
erotic or asteatotic Dry skin, frequently generalized
eratosis pilaris-like Perifollicular erythema or hype
ichen planus-like Purplish to markedly hyperpigm
reticulated or confluent; distr
vesiculobullous at times
ichen sclerosus-like May be indistinguishable from t
plaques, plugged follicles and
deeper layers of the dermis o
apulosquamous/psoriasiform Discrete guttate, annular or co
that may involve any part of
oikiloderma Variegated colors: erythema, h
suggestive of lupus when on t
yspigmentation May be punctate or confetti-lik
be associated with dermal fib
depigmentation suggestive of
eactive erythema Urticarial or annular plaques w
erythematosus
rythroderma Diffuse to generalized erythem
superficial erosions
cral erythema Diffuse or patchy erythema, ed
targetoid or erythema multif
resemble hand or foot eczem
ermal fibrosis, superficial Superficial and mid-dermal scle
epidermis may be normal, at
resembles morphea clinically
ippled or cellulite-like fibrosis Skin appears to be rippled in ar
caused by fibrosis of septae o
ermal/subcutaneous fibrosis Sclerosis involves all layers of th
bone; early on may be preced
bullae, and occasionally vascu
associated with neuropathy a
asciitis Superficial skin may have varyin
are seen along the course of
“prayer sign” is positive
ails Nails are generally thin with ve
entire nail may be lost; periu
calp Patchy or moth-eaten scarring
igure 1. Early cGVHD with abrupt onset xerosis and follicular
rominence in an annular distribution (rectangle) and small follic-
lar papules (arrows). sentric, or even dermatomal. Often there is an overlap
f lichen planus-like lesions and lichen sclerosis-like
esions as demonstrated in Figure 5b. Lichen planus-
ike GVHD may have vesicles, and these must be
Description
dandruff” on scalp or fishlike scale as in ichthyosis
ntation with papules or follicular keratotic, spiny protrusions
, polygonal papules with varying configurations: annular,
may be follicular, linear, dermatomal or lupus-like; may be
pathic variety with purple or gray-white smooth papules and
sis of the papillary dermis; at times associated with fibrosis of
inent atrophy
erythematous scaly patches and plaques with micaceous scale
dy including scalp, face, hands and feet
d hyperpigmentation with cigarette-paper epidermis;
rally considered to be a postinflammatory phenomenon; may
f varying depths and appear “leopard-like”; spontaneous
may be prominent
able scale resembling erythema annulare centrifugum or lupus
>80% of the body accompanied by scaling, localized bullae or
d pain of distal fingers, toes, palms and soles; may appear
ike with variable hyperkeratosis and erosions; early cases may
esulting in indurated plaques with variable pigmentation;
or bullous and skin can be moved over underlying structures;
h in adipose tissue-volar arms, abdomen and lateral thighs;
taneous fat
with loss of subcutaneous tissue, making it fixed to underlying
edema/lymphedema resulting in a peau d’orange appearance,
ors; pipestem fibrosis of the extremities is frequently
ful ulcers
ees of fibrosis or may not be fibrotic at all; prominent grooves
s; causes marked reduction of range of motion at joints;
idging and vertical pigment bands; pterygia may be seen and
elangiectasia is variable
ia with variable epidermal and pigmentary changes and scarring
igure 2. Early cGVHD with the new onset of ichthyosis (ﬁsh-like; “dry
rpigme
ented
ibution
he idio
sclero
r prom
nfluent
the bo
ypo- an
he face
e; gene
rosis o
vitiligo
ith vari
a over
ema an
orme-l
a
rosis r
rophic,
eas ric
f subcu
e skin
ed by
lar tum
nd pain
g degr
tendon
rtical r
ngual tcaling).
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Cutaneous Manifestations of cGVHD 1103istinguished from those of herpes simplex or varicella-
oster virus infection [3]. Disﬁguring postinﬂamma-
ory hyperpigmentation is a common problem with
ichen planus and lichen planus-like GVHD, espe-
ially in darker skinned individuals, and this may per-
ist despite intervention [4].
Other chronic eruptions that have traditionally
een designated “lichenoid” are often polymorphic. If
he epidermis is involved, the histologic picture will
ave lichenoid features; ie, there will be vacuolar de-
eneration of the basal layer, apoptotic cells within the
pidermis, and a perivascular lymphohistiocytic inﬁl-
rate irregardless of the clinical presentation. Clini-
ally, the morbilliform (measle-like papulosquamous)
ash that is seen in aGVHD occurs in cGVHD, usu-
lly after donor lymphocyte infusion or decrease in
mmunosuppressive medications. Although it can be
ifﬁcult to distinguish from drug eruptions, the pres-
nce of chronic lesions that persist despite elimination
f possible drug culprits, along with documented
VHD in other organ systems, helps to conﬁrm the
iagnosis. Persistent annular lesions reminiscent of
rticaria or other reactive erythemas such as erythema
nnulare centrifugum (Figure 6) is a striking presen-
ation. Erythrodermic cGVHD is often preceded by
apulosquamous, morbilliform, or annular eruptions
Figure 7).
Acral lesions are not uncommonly seen in
GVHD. The palms and soles may develop deep-
eated vesicles and scale suggestive of hand and foot
czema (Figure 8a,b), an acral erythema-like picture
ith edema, pain, and erosions, acral keratoses [3,5],
igure 3. Early cGVHD presenting with new onset of a keratosis
ilaris-like eruption (perifollicular papules with a central core
arked by arrow).r erythema multiforme-like lesions. sThe onset of cGVHD may also be marked by the
ppearance of lesions of cutaneous lupus and other con-
ective tissue disorders (Figures 9a,b). When present,
acial lesions may be crusted, lichen planus-like, or
oikilodermatous (characterized by atrophy, dyspig-
entation, and telangiectasia). Autoantibodies, espe-
ially antinuclear antibody, anti-Ro, and anti-La
Sjögren antibodies), are variably positive and their
igniﬁcance is unknown. Cutaneous cGVHD may also
e photodistributed even in the absence of detectable
utoantibodies.
Sclerotic skin changes are a prominent feature and
major source of morbidity in cGVHD. They may
evelop concurrently with other skin lesions or may
ccur independently. These can be divided by the
xtent of dermal, subcutaneous, and fascial involve-
ent [6]. Dermal ﬁbrosis may be superﬁcial or deep
nd subcutaneous ﬁbrosis may include the fascia, ten-
on, or fat septae. In some cases the onset is slow, with
ocalized waxy, bound-down sclerotic plaques resem-
ling morphea, preceded by variable erythema. When
he dermis alone is sclerotic, these plaques can be
oved over underlying structures such as bone. This
ay rarely occur in a linear distribution (Figure 10),
r in a dermatomal distribution, sometimes but not al-
ays at the site of antecedent zoster eruption. This
triking presentation may reﬂect changes in keratinocyte
ntigenicity due to the virus [7,8]. Leopard-like changes,
ith hyperpigmented, scaly macules, may be localized or
idespread and precede the sclerotic eruption [9].
Widespread, deep sclerotic lesions, especially over
oints and long bones, are devastating, and patients are
iterally “hidebound” with limited mobility. When
resent on the lower extremities, it results in the
ppearance of “pipestem legs” (Figure 11a), which
ay be accompanied by a painful neuropathy [10].
ventually, benign angiomatous tumors may develop
n this setting (Figure 11b) [11,12]. Bullae are a serious
igure 4. Psoriasiform GVHD. Note the well-deﬁned plaques with
ilvery scaling.
c
a
E
c
a
d
s
c
d
a
l
s
e
p
i
e
t
d
i
o
t
r
o
b
t
t
r
j
M
c
g
a
o
t
p
8
F
w
t
l
S. R. Hymes et al.1104omplication because they break down into ulcers that
re painful, slow healing, and a nidus of infection [13].
xtensive deep sclerosis of the thorax may further
ontribute to the restrictive lung problems already
ssociated with cGVHD. Fibrosis of tendons may pro-
uce a “grooving” sign (Figure 11c). Subcutaneous
eptal ﬁbrosis by itself may produce a rippling or
ellulite effect (Figure 11d) with little overlying epi-
ermal and dermal change. Alopecia and loss of skin
ppendages occurs as the skin becomes more ﬁbrotic,
eading to decreased sweating and an often irreversible
caring alopecia.
Abrupt and painful skin swelling associated with
rythema with or without subcutaneous edema or a
eau d’orange appearance characterizes deep fascial
nvolvement. This severe complication resembles the
osinophilia-myalgia syndromes and is resistant to
herapy [14]. Figure 12 shows acute limitation of wrist
orsiﬂexion (positive prayer sign) secondary to fasci-
igure 5. a, Lichen planus-like GVHD presenting with individual
hite plaques. The thin, hypopigmented, wrinkled, atrophic plaqu
he shoulder with lichen planus. c, Chronic GVHD presenting with
esions elsewhere.tis. The face is usually spared, and these changes may sccur independently or concurrently with ﬁbrosis of
he dermis or fat. Fifty percent of affected patients also
eport myalgias, and laboratory evaluation may dem-
nstrate peripheral eosinophilia [14]. A full-thickness
iopsy can be used, but is not necessary, to conﬁrm
he diagnosis. We have found it helpful to objec-
ively document disease progression and treatment
esponse by serial photographs, measurements of
oint mobility, and, in some cases, noninvasive 20-
Hz sonography [15].
Nail dystrophy is a common manifestation of
GVHD, with thickening, ridging, onycholysis, ptery-
ium, or complete nail loss. Periungual telangiectasias
re occasionally present. These changes affect single
r multiple nails, often correlate with the duration of
he disease, and cause considerable morbidity for the
atient [16] (Figure 13).
Mucous membranes are affected in approximately
0% of patients with cGVHD [17], resulting in ero-
ﬂuent purple polygonal plaques. b, Conﬂuent purple and atrophic
les) are characteristic of lichen sclerosis and the purple plaques on
lichenoid papules. This patient had more typical lichen planus-likeand con
es (circ
linearions, oral pain, and sicca symptoms that interfere
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Cutaneous Manifestations of cGVHD 1105ith nutrition and quality of life. A lacy, white net-
ork, Wickham striae, may develop on the buccal
ucosa, lips, and palate (Figure 14a). Other mucosal
nd gingival lesions become atrophic, erythematous,
r erosive (Figure 14b) and are indistinguishable from
rosive lichen planus. Atrophy of the tongue is asso-
iated with shortened or absent lingual papillae [18],
lthough elongation of papillae, geographic tongue,
nd white nondetachable plaques are also seen (Figure
4c). Chronic mucosal GVHD may predispose to
quamous cell carcinoma, and biopsies should be per-
ormed if this is suspected [19,20] (Figure 14d). When
he salivary glands are a target, xerostomia and dental
aries become problems [21]. Because of the distur-
ance in the epidermal barrier, topical or oral antifun-
al prophylaxis is advisable, as are antiviral agents.
Genital involvement affects sexuality and overall
uality of life [22]. After HSCT, symptoms of in-
dequate estrogenization occur secondary to prema-
ure ovarian failure, and this should be distinguished
rom early cGVHD. Vaginal GVHD develops an av-
rage of 10 months from transplantation and symp-
oms may include dryness, erosions, ulcerated or
hickened mucosa, narrowed or obliterated introitus,
requent vaginal infections, and symptoms of dyspa-
eunia [23]. Similarly, phimosis may occur in men.
ucosal strictures, like those of the esophagus, may
equire dilatation.
UMMARY
In this review, we developed a detailed descrip-
ion focusing on lesional morphology of cutaneous
GVHD. We hope this approach will result in the
dentiﬁcation of early changes of cGVHD and the
igure 6. Chronic GVHD presenting as an annular reactive ery-
hema resembling erythema annulare centrifugum. Note the bul-
ous lesion that showed histologic evidence of epidermal necrosis.evelopment of a common descriptive terminology. In
ddition to the effort of the National Institutes of
ealth Consensus Development Project on Criteria
or Clinical Trials in Chronic Graft-versus-Host Dis-
ase [1,24,25], we hope to contribute to systematize
he classiﬁcation of cutaneous cGVHD. The poly-
orphic nature of cutaneous cGVHD is poorly un-
erstood and this classiﬁcation system is a ﬁrst step in
reating different morphologic categories. From here
n, we intend to verify any correlation of lesional
orphology with outcome and response to therapy,
ith the hope of optimizing the management of this
ery complex group of patients.
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Cutaneous Manifestations of cGVHD 1107igure 8. a, Chronic GVHD presenting as acral erythema with deep-seated vesicles. b, Chronic GVHD presenting as painful palmer erythema
nd edema.
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S. R. Hymes et al.1108igure 9. a, Chronic GVHD presenting with a rash in a “butterﬂy” malar distribution. These lesions are poikilodermatous, showing hyper-
nd hypopigmentation, atrophy, and telangiectasia. b, Chronic GVHD presenting with erythema over the metacarpal interphalangeal,
roximal interphalangeal and distal interphalangeal joints.
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Cutaneous Manifestations of cGVHD 1109igure 10. Band-like deep dermal sclerosis presenting in a linear
attern.
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S. R. Hymes et al.1110igure 11. a, Sclerosis of the dermis and subcutaneous tissue producing “pipestem” legs with overlying erosions. b, Benign angiomatous
vascular) lesions appearing as a blue-black nodule in a patient with severe dermal sclerosis and resolving bullous changes with residual crusts.
iopsy may be necessary to establish the diagnosis and rule out a skin cancer. c, “Groove” sign (arrows) produced by ﬁbrosis around tendons.
, Rippling and “cellulite” appearance in the axillae produced by subcutaneous septal ﬁbrosis.
Cutaneous Manifestations of cGVHD 1111Figure 11. Continued
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S. R. Hymes et al.1112igure 12. Positive “prayer” sign (acute limitation of wrist dorsi-
exion) in a patient with fasciitis. This patient also has dermal
clerosis with dyspigmentation, a facial eruption in a butterﬂy dis-
ribution, and lichen planus-like lesions near the elbow. Her anti-
uclear antibody was positive at 1:640.igure 13. Nail loss in cGVHD, with periungual and nail bed
hanges.
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Cutaneous Manifestations of cGVHD 1113igure 14. a, Typical Wickham striae, a network of ﬁne lines, are seen on the lips of this patient with cGVHD. b, Erosive mucositis in
GVHD. c, Adherent white nondetachable plaques on the tongue in cGVHD. d, Chronic GVHD of the tongue complicated by documented
apilloma virus and biopsy proven squamous cell carcinoma.
